SmartSellTM - The New Way to Sell Online

Shop over 1.5 Million Toys in our Huge New Range

Critical Reviews in Tropical Medicine

Product Details

Promotional Information

Springer Book Archives

Table of Contents

1. The Special Programme For Research And Training In Tropical Diseases.- 1. Origins, Objectives, and Diseases.- 2. The Modus Operandi of the Programme.- 2.1. Scientific Working Groups.- 2.2. Research Strengthening Group.- 2.3. The Scientific and Technical Advisory Committee.- 2.4. Joint Coordinating Board.- 2.5. The Executing Agency.- 2.6. Budget.- 3. Research and Development.- 3.1. Malaria.- 3.2. Schistosomiasis.- 3.3 Filariasis.- 3.4. African Trypanosomiases.- 3.5. Chagas' Disease.- 3.6. Leprosy.- 3.7. Leishmaniasis.- 3.8. Epidemiology.- 3.9. Biomedical Sciences.- 3.10. Biological Control of Vectors.- 3.11. Social and Economic Research.- 4. The Strengthening of Research Capability.- 5. Field Research.- 6. Collaboration with Other Funding Agencies.- 7. Collaboration with Industry.- 8. Information on the Programme's Activities.- 9. An Interim Assessment.- 2. Infant and Child Mortality in Developing Countries.- 1. Introduction.- 2. Measuring Early-Age Mortality.- 3. Data Sources.- 3.1. Vital Registration.- 3.2. Censuses and Surveys.- 3.3. Surveillance Systems.- 4. The Age Pattern of Mortality.- 5. Early-Age Mortality Levels.- 5.1. Africa.- 5.2. Latin America.- 5.3. Asia.- 5.4. Summary.- 6. Early-Age Mortality Trends.- 6.1. Africa.- 6.2. Latin America.- 6.3. Asia.- 6.4. Summary.- 7. Early-Age Mortality and Levels of Per Capita Income.- 8. Intracountry Variation.- 8.1. Regional Variation.- 8.2. Urban-Rural Variation.- 8.3. Maternal Education.- 8.4. Birth Order, Birth Interval, and Maternal Age.- 8.5. Breast-Feeding.- 8.6. Birth Weight.- 8.7. Single or Multiple Births.- 8.8. Sex of Child.- 9. Causes of Early-Age Deaths.- 10. Synergistic Interrelations with Malnutrition.- 11. Further Factors.- 11.1. Water and Toilet Facilities.- 11.2. Health Service Availability.- 11.3. Climatic Seasonality.- 12. Infant versus Child Mortality.- 13. Conclusion.- References.- 3. Oral Rehydration Therapy.- 1. Introduction.- 2. Evolution of ORT.- 2.1. Early Empirical Use of ORT.- 2.2. Glucose-Linked Enhanced Sodium Absorption and Its Early Application in ORT.- 2.3. A Critical Look at the Scientific Basis of ORT.- 2.4. Oral Rehydration Formulation.- 3. ORT in the Community.- 4. ORT and Feeding Practices.- 5. ORS as an Absorption-Promoting Drug.- 5.1. Clinical Studies Supporting the Postulate.- 5.2. Future Prospects.- References.- 4. Functional Consequences of Iron Deficiency: Nonerythroid Effects.- 1. Immunocompetence and Infection.- 1.1. Immune Responses.- 1.2. Iron Status and Incidence of Infections.- 1.3. Iron Administration, Bacterial Growth, and Infection.- 2. Gastrointestinal System.- 3. Thermoregulation.- 4. Physical Work Capacity.- 4.1. Respiratory and Cardiovascular Adjustments.- 4.2. Human Studies.- 4.3. Animal Studies.- 4.4. Additional Comments.- 5. Cognition and Behavior.- References.- 5. Hypolactasia: Geographical Distribution, Diagnosis, and Practical Significance.- 1. Geographical Distribution of Primary (Genetically Determined) Hypolactasia and Persistence of Lactase.- 1.1. Distribution of PL in the Indian Subcontinent.- 1.2. Distribution of PL in Northern Africa.- 1.3. Distribution of PL in Europe.- 1.4. Incidence of PL in Southeast Asia, the Pacific, and Australia.- 1.5. Incidence of PL in Children in Population Groups with a High Incidence of Adult Hypolactasia.- 2. Explanations for the Survival of PL.- 2.1. The Culture-Historical Hypothesis.- 2.2. The Calcium-Absorption Hypothesis.- 2.3. The Water-Absorption Hypothesis.- 2.4. The Weaning-Time Hypothesis.- 2.5. The Linkage-Disequilibrium Hypothesis.- 2.6. The Rotavirus Receptor and Uncoating Hypothesis.- 2.7. Protection against Colonic Infections.- 2.8. Resistance to Systemic Infections.- 2.9. Synthesis of the Various Hypotheses.- 3. Genetics and Possible Undesirable Effects of PL.- 3.1. Atherosclerosis.- 3.2. Cataract Formation.- 4. Secondary (Acquired) Hypolactasia.- 4.1. Small-Intestinal Infections and Malignancy.- 4.2. Malnutrition.- 4.3. Dietary Depression of Lactase Concentration.- 4.4. Miscellaneous Small-Intestinal Diseases.- 5. Clinical Significance of Hypolactasia.- 5.1. Symptoms Attributable to Hypolactasia.- 5.2. Effect on Other Nutrients.- 5.3. Lactose and Milk Supplements in the Presence of Hypolactasia.- 5.4. Alleviation of Symptoms Associated with Hypolactasia.- 5.5. Management of Portal-Systemic Encephalopathy in Hypolactasia.- 5.6. Advantage of Hypolactasia in Reducing Intestinal Lead Absorption.- 5.7. Importance of Falling Lactase Concentration in Infant Malnutrition.- 6. Adaptation to Hypolactasia.- 6.1. Upper Gastrointestinal Factors in Adaptation.- 6.2. Colonic Adaptation.- 7. Diagnosis of Lactase Status.- References.- 6. Immune Response to Leishmania.- 1. Leishmania and Leishmaniasis.- 1.1. The Parasite.- 1.2. The Clinical Forms.- 2. The Immune Response of Man in Various Leishmanial Infections...- 2.1. Immune Response in Cutaneous Leishmaniasis.- 2.2. Immune Response in Mucocutaneous Leishmaniasis.- 2.3. Immune Response in Visceral Leishmaniasis.- 2.4. Immune Response in Aberrant Forms of Leishmaniasis.- 2.5. The Spectral Concept in Leishmaniasis.- 3. The Experimental Models of Leishmaniasis and Their Relevance to the Disease in Man.- 3.1. Genetics of Resistance and Susceptibility in Animal Models..- 3.2. Cutaneous Leishmaniasis.- 3.3. Visceral Leishmaniasis.- 4. Immune Response in Experimental Models of Infection.- 4.1. Immune Response of the Guinea Pig.- 4.2. Immune Responses of the Mouse.- 4.3. Miscellaneous.- 4.4. Assessment of the Role of Suppressor T Cells in the Outcome of the Disease.- 5. In Vitro Analysis of CMI Responses.- 5.1. The T Lymphocytes.- 5.2. The Killing of Leishmania by Macrophages.- 6. Analysis of Humoral Response to Leishmania Parasite.- 7. Conclusion.- References.- 7. Immunological Alterations in Chagas' Disease.- 1. The Parasite and the Disease.- 2. Immunity to T. cruzi.- 2.1. Natural Immunity.- 2.2. Acquired Immunity.- 3. Immunity to T. cruzi and Pathogenesis.- 3.1. Autoimmunity in T. cruzi Infections.- 3.2. T. cruzi-Induced Immunosuppression.- References.- 8. Immunity to Helminths and Prospects for Control.- 1. Introduction.- 2. Immunity to Helminths.- 2.1. Immunity in Vivo.- 2.2. Helminths as Antigens.- 2.3. Immune Responses.- 2.4. Restrictions on Immunity.- 2.5. Immunopathology.- 3. Immunologically Based Control.- 3.1. Vaccination against Infection.- 3.2. Vaccination against Transmission.- 3.3. Vaccination against Pathology.- 4. Summary and Conclusions.- References.- 9. Structured Vaccines for Control of Fertility and Communicable Diseases.- 1. Feasibility.- 2. Antifertility Vaccines.- 2.1. The Anti-hCG Vaccine.- 3. Structured Vaccines.- 3.1. Concept of Linkage with Carriers.- 3.2. Adjuvant Conjugation.- 4. Experience with Pr-?-hCG-TT Vaccine.- 4.1. Efficacy.- 4.2. Limitations of Pr-?-hCG-TT.- 4.3. Immunopotentiation by Adjuvants.- 4.4. The Problem of Constitutional Variability.- 5. Immunocontraception with Preformed Antibodies.- References.

Ask a Question About this Product More...
Write your question below:
Look for similar items by category
How Fishpond Works
Fishpond works with suppliers all over the world to bring you a huge selection of products, really great prices, and delivery included on over 25 million products that we sell. We do our best every day to make Fishpond an awesome place for customers to shop and get what they want — all at the best prices online.
Webmasters, Bloggers & Website Owners
You can earn a 5% commission by selling Critical Reviews in Tropical Medicine: Volume 2 on your website. It's easy to get started - we will give you example code. After you're set-up, your website can earn you money while you work, play or even sleep! You should start right now!
Authors / Publishers
Are you the Author or Publisher of a book? Or the manufacturer of one of the millions of products that we sell. You can improve sales and grow your revenue by submitting additional information on this title. The better the information we have about a product, the more we will sell!
Back to top